Loading...
XXI is not a good buy right now. The technical setup is still bearish (downtrend with bearish moving-average stack) and there are no Intellectia buy signals to override that. While the stock is sitting right on support and looks oversold enough for a short bounce, an impatient buyer is more likely to get chopped up than rewarded unless a clear reversal breaks back above the pivot zone (~8.39).
Price/levels: Last close ~$7.61, essentially sitting on S1 support (7.599). Next downside support is S2 (7.109). Overhead resistance starts at the pivot (8.394) then R1 (9.189).
Trend: Bearish. Moving averages are stacked bearishly (SMA_200 > SMA_20 > SMA_5), signaling the dominant trend is down.
Momentum: MACD histogram is negative (-0.258) but contracting, implying bearish momentum is still present though selling pressure may be easing.
RSI: RSI(6) ~24.7, which is effectively oversold territory and consistent with a potential dead-cat bounce—but oversold alone is not a durable buy signal in a downtrend.
Intellectia Proprietary Trading Signals
showed sharp YoY improvement in net income and EPS (Net Income +331.74% YoY; EPS +166.67% YoY).
Latest quarter: 2025/Q3. Revenue was 0 (0.00% YoY), while profitability improved sharply: Net Income 2,056,168 (+331.74% YoY) and EPS 0.16 (+166.67% YoY). This indicates a strong YoY earnings swing, but the lack of revenue growth makes the durability/quality of that earnings improvement unclear.
No analyst rating/price target change data was provided, so Wall Street pros/cons cannot be reliably summarized from this dataset. From the available trading/positioning data: hedge funds and insiders are neutral, which does not support a high-conviction bullish case right now. Congress trading data: no recent congress trading data available in the last 90 days.
